Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Eldred-Evans

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Translational Andrology and Urology|May 26, 2017
Use of botulinum toxin for voiding dysfunctionDavid Eldred-Evans, Prokar Dasgupta
Therapeutic Advances in Urology|January 3, 2017
Medium- to long-term outcomes of botulinum toxin A for idiopathic overactive bladderDavid Eldred-Evans, Arun Sahai
BJU International|March 2, 2019
Re-thinking active surveillance for the multiparametric magnetic resonance imaging eraDavid Eldred-Evans, Hashim U Ahmed
JAMA Oncology|August 19, 2021
Population-Based Prostate Cancer Screening With Magnetic Resonance Imaging or Ultrasonography-The IP1-PROSTAGRAM Study-ReplyDavid Eldred-Evans, Hashim U Ahmed
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|July 21, 2016
Impact of Laparoscopic Lens Contamination in Operating Theaters: A Study on the Frequency and Duration of Lens Contamination and Commonly Utilized Techniques to Maintain Clear VisionNathanael Yong, Philippe Grange, David Eldred-Evans
The Journal of Urology|November 28, 2017
Re: Long-Term Treatment with OnabotulinumtoxinA Results in Consistent, Durable Improvements in Health Related Quality of Life in Patients with Overactive Bladder: D. A. Ginsberg, M. J. Drake, A. Kaufmann, S. Radomski, A. E. Gousse, C. J. Chermansky, A. Magyar, J. P. Nicandro and V. W. Nitti; 191622-096 Investigators J Urol 2017;198:897-904Nicholas Faure Walker, David Eldred-Evans, Arun Sahai
International Journal of Surgery Case Reports|May 17, 2015
An unrecognised case of metabolic acidosis following neobladder augmentation cystoplastyDavid Eldred-Evans, Fahd Khan, Jay Abbaraju, et al.
BMC Medical Research Methodology|March 18, 2022
Adjusting for verification bias in diagnostic accuracy measures when comparing multiple screening tests - an application to the IP1-PROSTAGRAM studyEmily Day, David Eldred-Evans, A Toby Prevost, et al.
Current Urology Reports|August 18, 2020
Use of Imaging to Optimise Prostate Cancer Tumour Volume Assessment for Focal Therapy PlanningDavid Eldred-Evans, Henry Tam, Andrew P T Smith, et al.
Nature Reviews. Urology|July 23, 2020
Rethinking prostate cancer screening: could MRI be an alternative screening test?David Eldred-Evans, Henry Tam, Heminder Sokhi, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Translational Andrology and Urology|May 26, 2017
Use of botulinum toxin for voiding dysfunctionDavid Eldred-Evans, Prokar Dasgupta
Therapeutic Advances in Urology|January 3, 2017
Medium- to long-term outcomes of botulinum toxin A for idiopathic overactive bladderDavid Eldred-Evans, Arun Sahai
BJU International|March 2, 2019
Re-thinking active surveillance for the multiparametric magnetic resonance imaging eraDavid Eldred-Evans, Hashim U Ahmed
JAMA Oncology|August 19, 2021
Population-Based Prostate Cancer Screening With Magnetic Resonance Imaging or Ultrasonography-The IP1-PROSTAGRAM Study-ReplyDavid Eldred-Evans, Hashim U Ahmed
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|July 21, 2016
Impact of Laparoscopic Lens Contamination in Operating Theaters: A Study on the Frequency and Duration of Lens Contamination and Commonly Utilized Techniques to Maintain Clear VisionNathanael Yong, Philippe Grange, David Eldred-Evans
The Journal of Urology|November 28, 2017
Re: Long-Term Treatment with OnabotulinumtoxinA Results in Consistent, Durable Improvements in Health Related Quality of Life in Patients with Overactive Bladder: D. A. Ginsberg, M. J. Drake, A. Kaufmann, S. Radomski, A. E. Gousse, C. J. Chermansky, A. Magyar, J. P. Nicandro and V. W. Nitti; 191622-096 Investigators J Urol 2017;198:897-904Nicholas Faure Walker, David Eldred-Evans, Arun Sahai
International Journal of Surgery Case Reports|May 17, 2015
An unrecognised case of metabolic acidosis following neobladder augmentation cystoplastyDavid Eldred-Evans, Fahd Khan, Jay Abbaraju, et al.
BMC Medical Research Methodology|March 18, 2022
Adjusting for verification bias in diagnostic accuracy measures when comparing multiple screening tests - an application to the IP1-PROSTAGRAM studyEmily Day, David Eldred-Evans, A Toby Prevost, et al.
Current Urology Reports|August 18, 2020
Use of Imaging to Optimise Prostate Cancer Tumour Volume Assessment for Focal Therapy PlanningDavid Eldred-Evans, Henry Tam, Andrew P T Smith, et al.
Nature Reviews. Urology|July 23, 2020
Rethinking prostate cancer screening: could MRI be an alternative screening test?David Eldred-Evans, Henry Tam, Heminder Sokhi, et al.
Pageof 5